Paolo Manganotti Selected Research

Paolo Manganotti Research Topics

Disease

28	Stroke (Strokes) 11/2021 - 04/2008
12	Ischemic Stroke 09/2021 - 08/2018
8	COVID-19 06/2022 - 01/2020
6	Parkinson Disease (Parkinson's Disease) 06/2022 - 12/2002
6	Seizures (Absence Seizure) 10/2021 - 08/2009
5	Pain (Aches) 01/2022 - 07/2010
5	Multiple Sclerosis 01/2022 - 02/2018
5	Epilepsy (Aura) 11/2020 - 01/2013
5	Persistent Vegetative State (Vegetative State) 01/2019 - 01/2011
4	Headache (Headaches) 01/2022 - 10/2016
4	Cognitive Dysfunction 01/2022 - 11/2020
3	Infections 03/2022 - 09/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2019
3	Migraine Disorders (Migraine) 01/2022 - 07/2012
3	Disease Progression 01/2022 - 11/2002
3	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 01/2019
3	Status Epilepticus (Complex Partial Status Epilepticus) 10/2021 - 12/2018
3	Partial Epilepsies (Epilepsy, Partial) 01/2020 - 11/2014
3	Cerebellar Diseases (Cerebellar Syndrome) 02/2004 - 04/2003
2	Orthostatic Hypotension (Postural Hypotension) 06/2022 - 02/2022
2	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 03/2022 - 01/2018
2	Spasm (Spasms) 12/2021 - 02/2013
2	Inflammation (Inflammations) 09/2021 - 09/2016
2	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 10/2020
2	Infarction (Infarctions) 11/2020 - 03/2020
2	Fatigue 11/2020 - 07/2008
2	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 10/2020 - 05/2019
2	Neurobehavioral Manifestations 10/2020 - 01/2019
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2020 - 09/2019
2	Consciousness Disorders 01/2020 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 07/2008
2	Nervous System Diseases (Neurological Disorders) 02/2018 - 04/2013
2	Muscle Spasticity (Spastic) 01/2014 - 03/2007
2	Meniere Disease (Menieres Disease) 01/2014 - 07/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2022
1	Lymphoma (Lymphomas) 03/2022
1	Neoplasms (Cancer) 03/2022
1	Postural Orthostatic Tachycardia Syndrome 02/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Amyloidosis 11/2021
1	Tauopathies 11/2021
1	Pathologic Processes 11/2021
1	Carotid Stenosis (Carotid Artery Stenosis) 11/2021
1	Relapsing-Remitting Multiple Sclerosis 08/2021
1	Heat Stress Disorders (Heat Cramp) 04/2021
1	Out-of-Hospital Cardiac Arrest 03/2021
1	Cerebral Hemorrhage 03/2021
1	Synucleinopathies 01/2021
1	Corticobasal Degeneration 01/2021
1	Mixed Dementias 01/2021
1	Adenocarcinoma 01/2021
1	Dementia (Dementias) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021

Drug/Important Bio-Agent (IBA)

11	Cytidine Triphosphate (CTP)IBA 10/2021 - 08/2018
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2018
7	Pharmaceutical PreparationsIBA 10/2021 - 06/2011
6	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 03/2007
5	Botulinum Toxins (Botulinum Toxin)IBA 12/2021 - 03/2007
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2018
3	AntibodiesIBA 03/2022 - 05/2019
3	salicylhydroxamic acid (SHAM)IBA 11/2020 - 02/2007
3	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2020 - 09/2019
3	Anticonvulsants (Antiepileptic Drugs)IBA 10/2020 - 07/2014
2	SolutionsIBA 06/2022 - 01/2021
2	hydroxide ionIBA 06/2022 - 02/2022
2	Intravenous Immunoglobulins (IVIG)FDA Link 10/2021 - 01/2020
2	Bortezomib (Velcade)FDA Link 01/2021 - 07/2017
2	SynucleinsIBA 01/2021 - 01/2019
2	Dopamine (Intropin)FDA LinkGeneric 11/2020 - 01/2018
2	PrionsIBA 01/2020 - 01/2019
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020 - 01/2019
2	Levodopa (L Dopa)FDA LinkGeneric 01/2018 - 01/2009
2	TESIBA 04/2003 - 12/2002
1	AntigensIBA 03/2022
1	Dimethyl FumarateIBA 01/2022
1	nabiximols (Sativex)IBA 12/2021
1	InterleukinsIBA 09/2021
1	AcidsIBA 09/2021
1	Interleukin-6 (Interleukin 6)IBA 09/2021
1	Interleukin-8 (Interleukin 8)IBA 09/2021
1	N 30IBA 09/2021
1	teriflunomideIBA 08/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	BenzodiazepinesIBA 01/2021

Therapy/Procedure

17	Therapeutics 01/2022 - 03/2007
17	Transcranial Magnetic Stimulation 03/2021 - 12/2002
6	Transcranial Direct Current Stimulation 03/2022 - 12/2002
3	Thrombectomy 11/2021 - 07/2018
3	Extracorporeal Shockwave Therapy 01/2014 - 04/2010
2	Immunotherapy 03/2022 - 01/2021
2	Physical Therapy Modalities (Physical Therapy Technique) 01/2022 - 01/2019
2	Injections 12/2021 - 02/2013
2	Aftercare (After-Treatment) 07/2017 - 07/2010
2	Deep Brain Stimulation 01/2014 - 01/2011
2	Denervation 01/2014 - 07/2011
1	Duration of Therapy 01/2022
1	Carotid Endarterectomy 11/2021
1	Wearable Electronic Devices 04/2021
1	Induced Hypothermia 03/2021